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Abstract
Background: Malaria parasites are genetically polymorphic and phenotypically plastic. In studying transcriptome
variation among parasites from different infections, it is challenging to overcome potentially confounding technical
and biological variation between samples. We investigate variation in the major human parasite Plasmodium
falciparum, generating RNA-seq data on multiple independent replicate sample preparations of merozoite-containing
intra-erythrocytic schizonts from a panel of clinical isolates and from long-term laboratory-adapted clones, with a goal
of robustly identifying differentially expressed genes.
Results: Analysis of biological sample replicates shows that increased numbers improve the true discovery rate of
differentially expressed genes, and that six independent replicates of each parasite line allowed identification of most
differences that could be detected with larger numbers. For highly expressed genes, focusing on the top quartile at
schizont stages, there was more power to detect differences. Comparing cultured clinical isolates and laboratory-
adapted clones, genes more highly expressed in the laboratory-adapted clones include those encoding an AP2
transcription factor (PF3D7_0420300), a ubiquitin-binding protein and two putative methyl transferases. In contrast,
higher expression in clinical isolates was seen for the merozoite surface protein gene dblmsp2, proposed to be a
marker of schizonts forming merozoites committed to sexual differentiation. Variable expression was extremely
strongly, but not exclusively, associated with genes known to be targeted by Heterochromatin Protein 1. Clinical
isolates show variable expression of several known merozoite invasion ligands, as well as other genes for which new
RT-qPCR assays validate the quantitation and allow characterisation in samples with more limited material. Expression
levels of these genes vary among schizont preparations of different clinical isolates in the first ex vivo cycle in patient
erythrocytes, but mean levels are similar to those in continuously cultured clinical isolates.
Conclusions: Analysis of multiple biological sample replicates greatly improves identification of genes variably expressed
between different cultured parasite lines. Clinical isolates recently established in culture show differences from long-term
adapted clones in transcript levels of particular genes, and are suitable for analyses requiring biological replicates to
understand parasite phenotypes and variable expression likely to be relevant in nature.
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Introduction
Variation in gene expression is key to survival and
reproduction of microbes, affecting diverse phenotypes
such as sexual differentiation [1], adaptation to different
growth conditions [2] and evasion of host immunity [3].
Malaria pathogenesis occurs as parasites undergo cycles
of invasion and asexual replication inside erythrocytes.
Towards the end of each cycle, schizonts develop which
contain multiple merozoites that need to burst from the
host cell and invade new erythrocytes. The parasite tran-
scriptional program of the major human malaria parasite
Plasmodium falciparum is highly synchronised through-
out the asexual replication cycle in erythrocytes [4], but
some variation exists between parasite clones [5, 6].
Analysis of naturally occurring polymorphism in P. fal-
ciparum has shown that selection maintains multiple al-
leles of many merozoite-stage genes [7, 8], some of
which encode targets of naturally acquired immunity
[9–11]. Genes expressed at this stage can also exhibit ap-
parently pronounced variation in transcription among
parasites [7, 12–14], but most analyses have been con-
ducted on sample preparations that do not incorporate
many biological replicates, so that the extent of variation
among different parasite lines is unclear.
Accurate quantitation of differential gene expres-
sion between organisms or groups of organisms in
whole-transcriptome analyses requires biological rep-
licate sampling [15, 16]. The importance of minimis-
ing sampling error in order to detect real differential
gene expression is widely recognised [17], and some
bioinformatic tools can guide the determination of
replicate numbers appropriate to experimental designs
[18, 19]. In transcriptomic studies of malaria parasites,
achieving large numbers of replicate sample preparations
is difficult, particularly from clinical isolates [5], and most
detailed understanding of transcription has been derived
from a small number of parasite lines that have
been grown in culture for many years. Although
long-term culture-adapted parasites are phenotypically
and transcriptionally diverse [6, 12, 20], it is not clear to
what extent they reflect the diversity of parasites causing
clinical malaria. Examination of genome sequences of
culture-adapted parasites has identified premature stop
codon mutants affecting some transcription factor genes
and cell signalling protein genes [21, 22], as well as par-
ticular gene deletions and amplifications not seen in para-
sites sampled directly from patients [23–25].
Studies of parasite transcripts in clinical isolates face a
challenge of interpreting the mixture of developmental
stages that may be present in a blood sample, with para-
sites at different stages of the asexual cycle as well as para-
sites that have committed to sexual development [26–28].
Some of the unknown variation in parasite stage distribu-
tion may be accounted for using deconvolution methods
in analysis [28, 29], and some random variation may be
partly overcome statistically if it is possible to analyse large
numbers of infections [30, 31]. However, P. falciparum
parasites at the intra-erythrocytic schizont stage, contain-
ing merozoites ready to be released to invade other eryth-
rocytes, are normally sequestered in organ capillaries and
not present to be analysed in blood samples. This stage of
the parasite may be studied by ex vivo development in the
first cycle of following isolation from patients, and analysis
of matured schizont stages has shown variable expression
of particular genes [7, 13, 14], although the precision of
such analyses are limited without biological replicate
measurements.
Here we present gene expression profiles of schizont-stage
malaria parasites from recently culture-established clinical
isolates, and laboratory-adapted clones previously cultured
for many years. We conduct RNA-seq analysis with multiple
replicates of each parasite line, and show that high numbers
of biological replicates improves the true-positive discovery
rate for identifying differentially expressed genes. This iden-
tifies schizont-stage genes that have differing transcript levels
between the long-term laboratory-adapted clones and cul-
tured clinical isolates, as well as those variably expressed
among the clinical isolates. The results confirm variable
transcription in particular genes encoding ligands involved
in erythrocyte invasion, and variation in expression of genes
that have been less characterised was quantitatively validated
by targeted RT-qPCR assays, allowing analysis to be ex-
tended to additional samples from which material is more
limited. The expression levels of these genes in a panel of
clinical isolates cultivated to schizont stage in the first ex
vivo cycle were similar on average to those in continuously
cultured clinical isolates. This encourages use of recently cul-
ture-established parasite lines for studies requiring biological
replication.
Results
Biological replicate sampling improves detection of
differentially expressed genes
RNA-seq paired-end short-read sequences from all sam-
ples were mapped to the P. falciparum strain 3D7 refer-
ence genome sequence, and regions of genes with high
levels of allelic polymorphism were masked from ana-
lysis in order to minimize mapping bias among the dif-
ferent parasite lines (Additional file 1). Genes previously
described as deleted in some parasites were not ex-
cluded, as most individual deletions are very rare [32]
and exclusion would result in unnecessary loss of data
for genes unaffected in the isolates sampled. After ex-
cluding the subtelomeric large gene families var, rifin
and stevor for which short read sequence mapping is not
generally locus-specific, a total of 5134 gene loci were
analysed.
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We assessed the impact of numbers of biological repli-
cates on detection of genes with differing transcript
levels between parasite lines, by first analysing RNA-seq
data for the 3D7 and D10 laboratory clones, focusing on
schizonts purified by density gradient centrifugation
from ten different culture preparations of each clone.
Analysing data from all ten replicates identified 123
genes with adjusted P values < 0.01 and log2 differences
of > 2 in relative transcript levels between the two clones
(equivalent to at least 4-fold differences, Additional file 2).
We assessed what proportions of these 123 genes were
captured as being differentially expressed in 100 random
samples of two, four, six and eight replicates within each
group. The true-positive proportion of differentially
expressed genes detected (using the same statistical
criteria of absolute log2 fold difference > 2 and adjusted
P value < 0.01) increased with the number of replicates
within each group, median true-positive proportions be-
ing 0.28, 0.52, 0.67 and 0.79, for two, four, six and eight
replicates respectively (Fig. 1). These true-positives
accounted for the majority of genes indicated as differ-
entially expressed, out of median totals of 42, 81, 108
and 111 genes, for two, four, six and eight replicates re-
spectively. The median false-positive rates were very low
in all cases (among the genes that did not show differ-
ences with 10 replicates, the proportions showing appar-
ent differences with two, four, six and eight replicates
were 0.001, 0.004, 0.005 and 0.004 respectively).
We also examined the sensitivity to detect differential
expression when focusing specifically on genes that are
highly expressed in schizont-stage samples, as these in-
clude genes most likely to be functionally important for
the merozoite invasive stage. The FPKM values for each
sample in each of the comparisons were averaged and
the genes were ranked by their maximum expression
level. The top quartile of most highly expressed genes
were analysed for differences between clone 3D7 and
D10, in all ten replicates and subsamples of lower repli-
cate numbers, with 100 randomisations of each. In com-
parison with all ten replicates, there were median
true-positive rates of 0.45, 0.63, 0.78 and 0.86 for com-
parisons respectively containing two, four, six and eight
replicates, higher proportions than for the analysis of all
genes (Fig. 1). Based on these data, it is evident that in-
creasing biological replicate numbers for parasite
RNA-seq improves discovery, and under our experimen-
tal conditions the use of six independent biological repli-
cates detects the majority of genes shown to be
differentially expressed using ten replicates.
Comparison of gene expression in cultured clinical and
laboratory-adapted isolates
In addition to the ten biological replicate preparations from
each of clones 3D7 and D10 analysed above, another nine
biological replicate preparations of schizonts from clone
3D7 were analysed, as well as seven biological replicates for
each of two other laboratory-adapted clones (HB3 and
Dd2), and five or six replicates of each of six cultured clinical
isolates from Ghana (isolates 217, 278, 280, 286, 293 and
296: Additional file 3). Despite being enriched for mature
schizont stages, multiple biological replicates cannot each
have exactly the same distribution of parasite developmental
stages, so to assess stage variability the RNA-seq read depth
for each gene (FPKMs) for each replicate sample were corre-
lated with FPKM values in reference RNA-seq data for
seven cultured time points over a ~ 48 h P. falciparum cycle
[33]. This identified only a small number of replicate sam-
ples that did not have a maximum Spearman’s correlation
with parasites at schizont stages (either 40 or 48 h
post-invasion), and these were excluded from further ana-
lyses (Additional file 3). Although there is variation evident
among the remaining replicates that were analysed, within
each isolate the FPKMs among replicates correlated highly,
with average Spearman’s ρ > 0.95 for pairwise correlations
across all genes (Fig. 2).
Fig. 1 Increasing numbers of sample replicates improves identification
of schizont-stage genes varying in expression between different P.
falciparum lines. Assessment of the proportion of genes captured as
being differentially expressed between two different parasite clones
(3D7 and D10), by taking 100 random samples of two, four, six and
eight replicates of each (out of ten initially analysed replicates that
identified 123 genes with log2 differences of > 2 in relative transcript
levels between the two clones)
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In an overall comparison of the schizont preparations
from four long-term laboratory-adapted clones and six
cultured clinical isolates, 132 genes (2.6% of those ana-
lysed) appeared to have different transcript levels be-
tween the two groups, each having log2 fold difference >
2 and adjusted P value < 0.01 (Additional file 4). Among
the genes within the top quartile of expression values
overall, 18 genes (1.4%) had such a difference between
the groups, a lower proportion than among the rest of
the genes (Odds Ratio 0.52, Fisher’s exact P = 0.006).
Examining the 18 genes with differing transcript levels
among the top quartile of expressed genes, several were
seen to contain a deletion in one of the parasite lines or
to be members of multigene families. For example,
PF3D7_1371600 (ebl-1) and PF3D7_0935700 (near the
end of chromosome 9) are deleted in the HB3 strain and
D10 strain respectively (Fig. 3), as previously docu-
mented [34, 35]. After excluding these genes and others
for which one or more of the samples were presumed to
contain genetic deletions, and excluding members of
sub-telomeric multi-gene families, ten highly expressed
single-locus genes showed differences between labora-
tory and clinical isolates (Table 1).
There was considerable variation in the measurements
for individual genes among the different biological repli-
cate preparations of each parasite clone or isolate, with
five to ten-fold ranges of levels being not unusual (Fig. 3),
illustrating the importance of sampling and analysing
multiple biological replicates. To check for potential
effects of fine differences in schizont maturity among
samples, expression levels of the ten most differentiated
genes were compared between samples having overall
highest correlations with either the 40-h or the 48-h time
points of a reference transcriptome dataset [33]. This
showed that the gene expression distributions were not
due to differences in estimated maturity, and that differ-
ences between clinical isolates and laboratory clones
remained when only analysing replicates having peak cor-
relation with the 40-h time point (Additional file 5).
Eight of the ten highly expressed genes showing a differ-
ence between the groups had higher transcript levels in
the long-term laboratory-adapted clones than in the cul-
tured clinical isolates (Table 1). These include an AP2
transcription factor gene PF3D7_0420300, as well as two
predicted methyltransferase genes (PF3D7_0422900 and
PF3D7_0522300), and gene PF3D7_0104300 encoding
ubiquitin-binding protein 1 which is involved in protein
turnover [36] (Fig. 3). The genes that had higher transcript
levels in clinical isolates were PF3D7_1036300 which en-
codes the merozoite surface protein MSPDBL2 (Fig. 3),
and PF3D7_1302100 which encodes the gamete antigen
27/25. MSPDBL2 has previously been shown to be only
expressed in a minority of schizonts in culture, with clone
HB3 having more positive schizonts than other
laboratory-adapted clones [7], consistent with the higher
transcript level in HB3 seen here and previously. Recent
experimental analysis has shown mspdbl2 transcript levels
to be markedly increased in parasite cultures when func-
tion of heterochromatin protein 1 (HP1) is suppressed by
gametocyte development protein 1 (GDV1) leading to
gametocytogenesis [37, 38]. Although gamete antigen 27/
25 had higher transcript levels in clinical isolates and was
previously shown to be expressed in early gametocytes
[38, 39] another gene PF3D7_1327300 that is transcribed
in gametocytes [40] showed lower expression in the clin-
ical isolates (Table 1).
We investigated whether there was an overall association
between the genes differentially expressed and targets of
HP1 regulation [37, 41]. Of the HP1-regulated genes previ-
ously identified [37], 118 genes are among those analysed
here (var, rifin and stevor gene families were excluded). Of
the 132 genes differentially expressed between the two
groups, 24 (18.2%) were targets of HP1 regulation, a higher
proportion than among the rest of the genes (Odds Ratio
11.3, Fisher’s exact P = 1.3 × 10− 5).
Differential expression of schizont-stage genes among
cultured clinical isolates
Overall, 214 genes (4.2%) showed a log2 fold difference > 2
for at least one of the 15 pairwise comparisons among cul-
tured clinical isolates. Of those genes in the top quartile of
expression levels, 39 genes (3.0%) showed a difference for
at least one pairwise comparison, a lower proportion than
Fig. 2 Distribution of correlations of FPKM expression values among
biological sample replicate transcriptomes for each isolate or clone.
The final numbers of replicates, and median Spearman’s correlation
coefficients among replicates were: 3D7 n = 19, ρ = 0.89; D10 n = 10,
ρ = 0.93; Dd2 n = 6, ρ = 0.95; HB3 n = 7, ρ = 0.89; 271 n = 3, ρ = 0.94;
278 n = 5, ρ = 0.91; 280 n = 6, ρ = 0.93; 286 n = 6, ρ = 0.97; 293 n = 6,
ρ = 0.93; 296 n = 3, ρ = 0.90
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Fig. 3 Gene transcript levels among preparations of schizont-enriched P. falciparum cultures of laboratory-adapted clones and clinical isolates. Plots of
normalised RNA-seq read counts for eight of the genes showing differences between four long-term laboratory-adapted clones (3D7, D10, Dd2 and
HB3) and six recently culture-established Ghanaian clinical isolates (271, 278, 280, 286, 293 and 296). Each point shows the value for an independent
biological replicate sample. For all genes, a wide variation in transcript levels among biological replicates may be noted. a The two panels show
examples of genes for which one of the laboratory-adapted clones had a deletion, D10 which is missing the PF3D7_0935700 gene as part of a deleted
region near the end of chromosome 9, and HB3 which is missing gene PF3D7_1371600 that encodes erythrocyte binding-like protein 1. These, and
other genes with suspected or known deletions in the sampled parasites, are excluded from the list of differentially expressed genes in Table 1 but are
listed Additional file 4: Table S2. b The six panels show examples of genes listed in Table 1 that are in the top quartile of expression and show a log2
fold difference > 2 between the groups. Most of these genes have lower transcript levels in the clinical isolates (including AP2 transcription factor gene
PF3D7_0420300, as well as predicted methyltransferase genes PF3D7_0422900 and PF3D7_0522300, and ubiquitin-binding protein 1 gene
PF3D7_0104300). In contrast, the mspdbl2 gene PF3D7_1036300 shown in the bottom right panel had higher transcript levels in clinical isolates
Table 1 P. falciparum genes in the top quartile of expression showing a difference in schizont stage transcript levels between long-
term laboratory-adapted clones and recent clinical isolates in culture
Gene ID Product annotation Log2 fold difference Wald test
Higher transcription in long-term laboratory-adapted clones
PF3D7_0422900 methyltransferase, putative −2.50 −6.48
PF3D7_0501300 skeleton-binding protein 1 −2.50 −4.98
PF3D7_0410000 erythrocyte vesicle protein 1 −2.38 −10.62
PF3D7_0104300 ubiquitin carboxyl-terminal hydrolase 1, putative −2.18 −6.13
PF3D7_0522300 18S rRNA (guanine-N(7))-methyltransferase, putative −2.15 −8.67
PF3D7_0420300 AP2 domain transcription factor, putative −2.02 −7.19
PF3D7_1030200 claudin-like apicomplexan microneme protein, putative −2.00 −9.21
PF3D7_1327300 conserved Plasmodium protein, unknown function −2.00 −4.97
Higher transcription in clinical isolates
PF3D7_1036300 duffy binding-like merozoite surface protein 2 3.02 5.32
PF3D7_1302100 gamete antigen 27/25 2.02 3.99
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among the less expressed genes (Odds Ratio 0.66, Fisher’s
Exact P = 0.02) (Additional file 6). Some of the variably
expressed genes encode merozoite proteins previously
characterised as transcriptionally variable among ex vivo
clinical isolates [14], including dblmsp2 and msp6, as well
as erythrocyte binding antigen genes eba-175, eba-181,
and eba-140 (which is also deleted in one of the laboratory
adapted clones) (Additional file 7). Notably, among the 214
genes variably expressed among cultured clinical isolates, 38
(17.8%) have been shown to be targets of HP1 regulation,
compared with only 1.6% of the non-variably expressed
genes (Odds Ratio 12.9, Fisher’s Exact P < 2.2 × 10− 16). This
association was even more extreme among genes in the top
quartile of overall expression values, 16 (41%) of the 39 vari-
ably expressed genes being targets of HP1 regulation com-
pared with only 0.6% of the non-variably expressed genes
(Odds Ratio 118.6, Fisher’s exact P < 2.2 × 10− 16).
To validate the data obtained through RNA-seq, a
subset of genes was selected for quantitation by
reverse-transcription quantitative PCR (RT-qPCR). We
chose differentially expressed genes encoding proteins
containing predicted transmembrane domains or signal
peptides, thereby likely to enter the parasite secretory
pathway, excluding genes previously characterised as
variably expressed or members of multi-gene families.
Eight genes were selected for assay (Additional file 8),
two of which encode known antigens (merozoite-asso-
ciated tryptophan-rich antigen [42] and liver-stage
antigen-3 [43]). These gene transcripts were quantified
by RT-qPCR in 49 RNA preparations from the laboratory
clones and clinical isolates that had been analysed by
RNA-seq. Transcript levels were normalised to those of a
housekeeping gene (serine-tRNA ligase PF3D7_0717700)
and correlated with similarly normalised FPKM expres-
sion values for the RNA-seq data. Each gene showed
strong positive and highly significant correlation between
RNA-seq and RT-qPCR-derived expression measures, all
except one having correlation coefficients > 0.8 (Fig. 4).
Variable expression among isolates with schizonts
sampled in the first ex vivo cycle
We next determined the expression levels in additional
clinical samples from Ghana matured during the first
cycle ex vivo until a large proportion of parasites were
schizonts. For nine of these isolates there was sufficient
RNA yield for RNA-seq to be performed, out of which
seven gave adequate data for transcriptome ana-
lysis. With remaining material from two of these as well
as another six isolates there was sufficient to analyse the
selected eight gene panel by RT-qPCR. Characterisation
of the ex vivo samples showed considerable variation in
relative expression levels of each gene, but the mean
levels across the isolates were similar to those deter-
mined in the continuously-cultured parasites that had
extensive sample replication (Fig. 5). Without sample
replication of the first cycle ex vivo clinical samples,
Fig. 4 High correlations between RNA-seq and RT-qPCR expression measures. Eight genes identified as differentially expressed among clinical isolates
by RNA-seq were validated by RT-qPCR for 49 of the independent RNA preparations from the four laboratory-adapted clones and six cultured clinical
isolates under study. Scatter plots for each gene show the RT-qPCR gene of interest (GOI) copies (log2-transformed) normalised to house-keeping
gene copies (HKG; PF3D7_0717700), correlated with the RNA-seq GOI FPKM values (log2-transformed) normalised to HKG FPKM values. Spearman’s
correlation coefficients are shown for each plot
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routine technical variation and random sampling effects
are likely to exaggerate the apparent variation in expres-
sion levels. However, the observation that for each gene
the normalised expression values have similar means to
those for cultured clinical lines indicates there are no
systematic differences in expression between the first ex
vivo cycle and under continuous culture conditions.
These results support the use of cultured clinical isolates
as a means of studying parasite gene expression reflect-
ing original populations, while enabling the necessary
experimental replication for many analyses.
Discussion
Transcriptomic analyses perform optimally with increased
levels of sample replication to minimise the impact of sto-
chastic or technical variation in individual samples [17,
44]. This is particularly important for studies focusing on
a defined developmental stage, as errors may be caused by
subtle differences between samples. However, the nature
of clinical samples of malaria parasites is such that replica-
tion is technically very difficult. In order to assess the de-
gree of replication useful to identify differentially
expressed genes, we first generated RNA-seq profiles from
multiple replicates of laboratory-adapted clones, and used
the data to calculate the true- and false-discovery rates ob-
tained using fewer replicates. Consistent with studies on
other cultured eukaryotes [17], we show that for malaria
parasites increasing the sample replication improves the
true-positive discovery rate in identifying variably
expressed genes, and under the experimental conditions
here six independent replicates were useful to balance ac-
curacy and experimental feasibility. Where these numbers
of replicates are not obtainable, it is recommended to
focus on genes that are highly expressed in order to
achieve as much accuracy as possible per gene. Con-
versely, where a very high sensitivity is needed it may be
worth studying even more biological replicates for each
parasite line and condition being investigated.
It has been proposed that spontaneous transcrip-
tional variation within parasite populations is a strat-
egy that ensures fitness of parasites facing a range of
potential and changing selective pressures [6], and it is
likely that the rates and mechanisms of regulation
differ among most genes. In comparison between
long-term laboratory-adapted clones and cultured clin-
ical isolates, we found that among the genes most dif-
ferentially expressed were an AP2-transcription factor
[45] and two methyltransferases, the functional roles of
Fig. 5 Transcript levels of variably expressed genes for first cycle ex vivo clinical samples compared with continuously cultured isolates. For each
gene, the log2 normalised expression value is plotted as a ratio of the value for a housekeeping gene (PF3D7_0717700). For the cultured clinical
isolates (red, N = 6), each point represents the mean expression value for each gene calculated across multiple replicates of each isolate. For the
ex vivo clinical isolates, each point represents values for single samples without replicates. The panel of ex vivo A samples (green N = 8) were
analysed by RT-qPCR, while the panel of ex vivo B samples (black, N = 7) were analysed by RNA-seq
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which remain to be determined although genome-wide
mutagenesis studies indicate they are important for P. fal-
ciparum asexual erythrocytic stage replication [46]. It is
possible that use of different oxygen concentrations in the
culture of long-term adapted clones and recent clinical
isolates here might affect transcription of some genes, par-
ticularly in earlier trophic stages of the intra-erythrocytic
cycle [47], and although we did not consider oxygen me-
tabolism in analysis of schizont stages it could be exam-
ined in future. Most of the differentially expressed genes
noted here had lower transcription in the clinical isolates,
and we note that HP1 is responsible for extensive gene si-
lencing in malaria parasites [38], and there was an over
representation of HP1-regulated genes among those dif-
ferentially expressed between laboratory-adapted clones
and cultured clinical isolates. It would be interesting to
undertake studies directly on HP1 and other chromatin
modifications in recent clinical isolates, as experimental
studies on chromatin have so far focused on long-term
laboratory-adapted clones. Interestingly, among the top
quartile of expressed genes, the one most markedly highly
expressed in clinical isolates was mspdbl2 that encodes a
merozoite surface protein expressed within only a minor-
ity of schizonts [7] which may be a marker of parasites
committed to sexual development [37]. Further studies of
clinical isolates are needed to understand the process of
parasite commitment to sexual differentiation and trans-
mission, as indicated by other transcriptome comparisons
[5, 30].
We identified many genes differentially expressed among
the clinical isolates. Targeted RT-qPCR assays of
schizont-stage ex vivo cultured clinical isolates have previ-
ously shown some of the genes to be differentially
expressed [7, 13, 14]. Focusing on genes for which variable
expression has not been previously studied, we selected a
panel of eight highly differentially expressed genes that en-
code secreted proteins. Of these, the merozoite-associated
tryptophan-rich antigen and liver stage antigen 3 have
been previously identified as merozoite proteins [42, 43],
and another gene (PF3D7_0423900) is adjacent to loci en-
coding the cysteine-rich protective antigen (CyRPA) and
reticulocyte binding homologue 5 (Rh5) which are targets
of antibodies that inhibit merozoite invasion. We exten-
sively validated the RNA-seq data by RT-qPCR for these
genes, and extended quantitation to additional ex vivo
clinical isolate samples. Despite the lack of sample repli-
cates for the latter, results showed that average expression
levels for each gene were similar to those for the cultured
samples that had biological replicates.
Together, these data highlight new candidates for investi-
gation as potential determinants of alternative developmen-
tal pathways or targets of immunity. Characterisation of
gene transcript levels is only one level of analysis, as prote-
omic characterisation [48] and analysis of phosphorylation
and other protein modifications [49, 50] may also identify
functional determinants, and large-scale analysis of parasite
protein variation has not yet been attempted on clinical iso-
lates. A more complete description of transcriptome vari-
ation may also be derived in future by analysis of individual
infected cells, which has not been undertaken on parasites
from clinical isolates, as initial single-cell sequencing studies
of laboratory model malaria parasites have only recently
begun to probe the expression pathways of different
life-cycle stages [51–53]. Scaling up transcriptomic analyses
to clinical studies is challenging, and biological replicate
preparations of parasite samples may only be feasible in a
limited number of cases. In an epidemiological context, re-
duction of error also requires large sample sizes and tight
definition of clinical phenotypes, and more statistical ana-
lysis and modelling of covariates may be appropriate, ideally
including data on host transcriptome variation within the
same samples [54].
Conclusions
The transcriptomes of Plasmodium falciparum erythrocytic
schizont preparations of long-term laboratory-adapted
clones and recently established clinical isolates were ana-
lysed, using large numbers of biological replicate samples
to minimise the impact of inter-replicate variation on ob-
served patterns of differential expression. Testing subsam-
ples of up to ten replicates of each cultured line shows that
six replicate preparations gives power to detect most differ-
ences. Particular genes show differential expression in
laboratory-adapted clones compared to cultured clinical
isolates, or among different clinical isolates, including those
predicted to affect differentiation and encoding targets of
immunity. In schizonts grown in the first cycle ex vivo, ex-
pression levels of a panel of these genes vary among iso-
lates, but mean levels are similar to those in continuously
cultured clinical isolates suitable for experimental analyses
requiring biological replicates to understand relevant para-
site phenotypes.
Methods
P. falciparum isolates sampled from clinical malaria cases
Blood samples were collected from clinical malaria cases
attending Ghana government health facilities between
2012 and 2013, in Kintampo (Brong-Ahafo Region of
central Ghana), and Navrongo (Kassena-Nankana East
Municipality, in the Upper East Region of northern
Ghana). Patients were eligible to participate in the study if
they had uncomplicated clinical malaria, were aged 2–14
years, tested positive for P. falciparum malaria by lateral
flow rapid diagnostic test and slide microscopy, and had
not taken antimalarial drugs during the 72 h preceding
sample collection. Venous blood samples (up to 5ml) were
collected into heparinized Vacutainer tubes (BD Biosci-
ences). Blood samples were centrifuged, plasma separated
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and leukocyte buffy coat cell layer removed, and erythro-
cytes were cryopreserved in glycerolyte and stored frozen at
− 80 °C or in liquid nitrogen until shipment on dry ice to
the London School of Hygiene and Tropical Medicine for
subsequent culture.
Parasite culture and enrichment for schizont stages
Parasites from ex vivo clinical samples were matured
within the original patient erythrocytes at 2–5% haema-
toctit for up to 48 h in RPMI 1640 medium containing
2% human AB serum (GE Healthcare) and 0.3% Albu-
max II (Thermo Fisher Scientific) under an atmosphere
of 5% O2, 5% CO2, and 90% N2 at 37 °C, until most para-
sites were at the schizont stage of parasite development.
Laboratory-adapted clones and continuously cultured
clinical isolates were grown in erythrocytes at 2–5% haem-
atocrit in RPMI 1640 medium containing 0.5% Albumax
II, at 37 °C. The biological replicate schizont preparations
of clinical isolates for RNA-seq analysis were made by
sampling at multiple time points between 182 and 250
days after first initiation into continuous culture.
Laboratory-adapted clones which have been in culture for
many years (3D7, HB3, Dd2, and D10) were maintained
under atmospheric air with 5% CO2, and cultured clinical
isolates were maintained in 5% O2, 5% CO2, 90% N2.
Schizonts were purified using magnetic-activated cell sort-
ing (MACS) for all of the lines, except for the D10 and
HB3 clones and ten of the 3D7 replicates which were puri-
fied using Percoll density gradient centrifugation.
For MACS purification of cultured clinical isolates,
parasites were prepared from 100ml cultures with at
least 0.7% of erythrocytes containing schizonts. Parasites
were isolated by magnetic purification using magnetic
LD Separation columns (Miltenyi Biotech). One column
was used per 25ml culture, and first washed twice in 3ml
of culture medium at room temperature. Parasite culture
erythrocytes were pelleted by centrifugation at 500 g for 5
min, then re-suspended in 3ml culture medium per 1ml
of packed cell volume. The re-suspended material was
bound to the MACS column, which was then washed
three times with 3ml culture medium, and schizonts were
eluted twice by removing the magnet from the column
and forcing 2ml culture medium through the column into
a 15ml collection tube. Finally, the schizonts were pelleted
by centrifugation at 500 g for 5min and the pellet volume
was estimated, with 0.5 μl used for Giemsa-stained micro-
scopical examination to assess staging, 1 μl added back to
250 μl culture at 0.8% hematocrit to follow the progres-
sion. Remaining parasites were re-suspended in 1.5ml of
culture medium with 10 μM E64 in a 12 well plate, and
parasites were incubated for 5.5 h in 5% CO2 at 37 °C, be-
fore centrifugation in a 1.5ml tube and processing for
RNA extraction.
For discontinuous density centrifugation purification,
parasites were maintained as 25 ml cultures at 2.5%
hematocrit. Cultures were used when > 1% erythrocytes
contained parasites with multiple nuclei. Schizonts were
purified using 70% Percoll (GE Healthcare)/2.93% sorb-
itol/PBS overlayed with 35% Percoll/1.47% sorbitol/PBS,
which was overlayed with parasitized erythrocytes,
allowing the schizonts to be separated by centrifugation
at 2500 g for 10 min at 24 °C, with a light brake at the
end of centrifugation. Purified schizonts were washed
once in complete medium and the pellet volume was es-
timated, following which the pellet was resuspended
with six times the pellet volume of 50% haematocrit
erythrocytes, a slide was prepared for microscopic exam-
ination, and the cells were then incubated in 6 ml of
complete culture medium. Of this, 1 ml was used as a
control untreated sample to track parasite egress, and
10 μM final concentration of E64 was added to the
remaining 5 ml, and both were cultured at 37 °C in a 5%
CO2 static incubator for 5.5 h. Schizonts from the
E64-treated culture were overlaid on 70% Percoll/2.93%
sorbitol/PBS and separated by centrifugation at 2500 g
for 10 min at 24 °C, with a light brake at the end of cen-
trifugation. The schizont layer was washed once in
complete culture medium and final cell pellets of ap-
proximately 10–20 μl were used for RNA extraction.
RNA extraction
Erythrocytes containing the prepared schizonts were re-
suspended in 500 μl TRIzol® reagent (Thermo Fisher Sci-
entific) and stored at − 80 °C until RNA extraction using
RNeasy mini columns (Qiagen). RNA pellets were dis-
solved in 100 μl RNase-free H2O, and a second RNA
clean-up and on-column DNase treatment was carried
out with RNA eluted in 30–50 μl RNase-free H2O, and
concentration quantified by Qubit High Sensitivity RNA
Assay (Thermo Fisher Scientific). Samples containing at
least 500 ng RNA were considered for RNA-seq process-
ing after the RNA integrity was checked on an Agilent
Bioanalyzer using RNA 6000 Nano reagents and chips
(Agilent Genomics).
RNA-seq library preparation and sequencing
RNA-seq libraries of each of the replicate preparations
of parasites were prepared with TruSeq Stranded mRNA
Library Prep Kits (Illumina) using 500 ng – 1 μg RNA
following the Illumina TruSeq Stranded mRNA protocol.
Libraries were validated on an Agilent Bioanalyzer using
DNA 1000 reagents and chips (Agilent Genomics) to
quantify library sizes and confirm the absence of primer
dimers. Libraries were quantified using a KAPA
Universal Library Quantification kit (Roche Diagnostics
Limited) on a 7500 Fast Real-Time PCR System
(Thermo Fisher Scientific) and library concentrations
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were adjusted for library size. 12–15 pM pooled libraries
were sequenced on a MiSeq System (Illumina) using a
MiSeq Reagent Kit v3 (Illumina) with 2 × 75 cycles.
RNA-seq libraries of ex vivo schizont-enriched P. fal-
ciparum isolates (not cultured beyond the first cycle)
were prepared using a modified protocol. PolyA+ RNA
(mRNA) was selected using magnetic oligo-d(T) beads,
and mRNA was reverse transcribed using Superscript
III® (Thermo Fisher Scientific), primed using oligo-d(T)
primers, with dUTP included during second-strand
cDNA synthesis. The resulting double stranded cDNA
was fragmented using a Covaris AFA sonicator. Sheared
double stranded cDNA was dA-tailed, end repaired, and
“PCR-free” barcoded sequencing adaptors (Bioo Scien-
tific) [55] were ligated. Libraries were cleaned twice,
using solid phase reversible immobilisation beads, and
eluted in EB buffer (Qiagen). Second strand cDNA was
removed using uracil-specific excision reagent enzyme
mix (NEB) prior to library generation, and libraries were
assayed by quantitative PCR prior to sequencing on
a HiSeq system (Illumina).
Data analysis
Raw Illumina sequence reads were aligned to the P. fal-
ciparum 3D7 v3 genome using HISAT2 [56] and con-
verted to ‘BAM’ format using SAMtools [57]. Reads with
MAPQ scores < 60 were removed. Reads were counted
using the “summarizeOverlaps” feature of the Genomi-
cAlignments package [58] in R, against a previously pub-
lished P. falciparum genome annotation file that had
been masked for regions of polymorphism (outlined in
Additional file 1, which explains the coded annotation in
Additional files 9 and 10). Fragments Per Kilobase of
transcript per Million mapped reads (FPKMs) for the data
here and those of previously published data on a develop-
mental time course of the clone 3D7 [33] were calculated
using the ‘fpkm’ function of DESeq2 [59] in R. FPKMs for
all genes in each of our parasite preparations were corre-
lated using a Spearman’s Rank correlation with FPKMs for
each of the seven time points (0, 8, 16, 24, 32, 40 and 48 h
post-invasion; Additional file 2: Table S1). Replicates with
peak Spearman correlation values of ρ > 0.7 at the latest
time points (40 or 48 h) were included for further analysis.
Differential expression analysis was conducted using
DESeq2 in R.
To test that the protocol for E64 treatment to prevent
schizont egress from erythrocytes had no major effect
on the transcriptomes, a comparison of four paired rep-
licates of schizont preparations of cultured P. falciparum
clone 3D7 was performed, which showed that only a sin-
gle gene had log2 fold difference > 2 (Additional file 11),
a difference considered as potentially random and
marginal compared to differences anticipated between
different parasite lines. The E64 treatment as described
above enabled efficient preparation of mature schizonts,
so this was used for preparations of schizonts through-
out the study.
RT-qPCR assays
150–500 ng total RNA from each preparation of parasite
schizonts was reverse transcribed using Superscript II®
(Thermo Fisher Scientific) with 250 ng random hexamer
oligonucleotide primers per 20 μl reaction. Quantitative PCR
(qPCR) was carried out using SYBR® Select Master Mix
(Thermo Fisher Scientific) with 500 nM forward and reverse
primers, in a Prism 7500 Fast qPCR machine. For each gene,
threshold-cycle values were quantified against a serially di-
luted genomic DNA (Dd2 strain) standard curve, run on the
same plate. Cycling parameters were: 50 °C for 2min, 95 °C
for 2min followed by 40 cycles of 95 °C for 15 s and 60 °C
for 1min. All wells were run as 10 μl volumes in technical
duplicate. The qPCR copy numbers were normalised against
copies of a house-keeping gene, PF3D7_0717700 [60]. PCR
primer pair sequences are as follows: PF3D7_0102700
5’-CAACCAGACAAACAACAAGAAA-3′ and 5’-TCCAT
TCTGATGCTTTCCAC-3′, PF3D7_0220000 5’-GTAAAT
GGTGAATTAGCTAGTGAAG-3′ and 5’-CCTTTATATC
TTCGGCTTCTTCT-3′, PF3D7_0423900 5’-GAGAAGAA
GCCAAAGTAAATGAAC-3′ and 5’-GAATGTGTCAAG
TGCATCATAA-3′, PF3D7_0605900 5’-CGCAATAACAA-
GAAGTCACAAA-3′ and 5′-AAGATTGTAGGAGGGTG
TTAAT-3′, PF3D7_0935300 5’-GGGCTGCTGTTATACC
TTG-3′ and 5’-AGAATGAGGAGGTTCAGTTTG-3′, PF3
D7_1252900 5’-CCTTAGTAGAACTTCAAAGTGACA-3′
and 5’-TGTAACCAACTACGAAATTCCC-3′, PF3D7_14
61700 5’-TGCTGACTTTCAAGAGATAAGG-3′ and 5’-T
TTCATTTGTTCATTTTGTACAACC-3′, PF3D7_147650
0 5’-CTTCGATTCACAAATGCAGAAA-3′ and 5’-CGTA
TTCCACACCTTGTTCTAT-3′, PF3D7_0717700 5’-AAG-
TAGCAGGTCATCGTGGTT-3′ and 5’-GTTCGGCACAT
TCTTCCATAA-3′.
Additional files
Additional file 1: Masking of P. falciparum genome annotation file to
exclude polymorphic regions of genes. (PDF 546 kb)
Additional file 2: Table S1. List of genes with different detected transcript
levels between 3D7 and D10 strains by absolute log2 fold > 2 (at least 4 fold
difference). Note that this list contains some genes that are deleted in either
line. There are also two highly polymorphic genes that were not masked in
the initial annotation file, asterisked below (*) and excluded from subsequent
analyses. (XLSX 18 kb)
Additional file 3: Figure S1. Multiple biological replicate preparations of
P. falciparum schizont stage transcriptomes in correlation with reference
stage-specific transcriptome data. Multiple parasite preparations were made
from four long-term laboratory adapted clones (between seven and ten
replicates of each) and six Ghanaian clinical isolates (five or six replicates of
each) for RNA-seq analysis. Each parasite culture was enriched for schizont-
stage parasites, with egress blocked using E64 treatment. Plots show the
correlations of FPKM values across all genes in comparisons with previous
data from seven time-points across the P. falciparum asexual erythrocytic
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cycle [33], with peak correlations indicating the predominant parasite stage in
each replicate. Red lines plot data for samples with peak correlation at either
40 or 48 h post-invasion, and grey lines plot replicate samples that did not
maximally correlate with either of these time points, which were therefore
excluded from further analysis. (TIFF 92 kb)
Additional file 4: Table S2. Genes showing significant differences in
transcript levels (log2 fold > 2, at least 4 fold difference on average) in
comparison of six cultured clinical isolates and four long-term laboratory
adapted clones, including all biological replicate samples. For genes among the
top quartile of expression values genome-wide (top 18 genes in the table),
members of multigene families and genes in which strain-specific deletions
may be responsible for differences are annotated with asterisks (*). (XLSX 20 kb)
Additional file 5: Figure S2. Normalised read counts for the ten most
highly differentiated genes between cultured clinical isolates and laboratory-
adapted clones. Individual sample replicates are plotted according to the time
of overall peak transcriptome correlation with reference time course data
(either 40 or 48 h). Replicates from clinical isolates are in red (those having
peak correlation with 40 h are plotted), and replicates from laboratory isolates
are in blue. (PDF 312 kb)
Additional file 6: Table S3. Log2 fold differences in transcript levels of
genes differentially expressed among pairwise comparisons of six
cultured clinical isolates with multiple schizont preparations of each,
among genes within the top quartile of expression overall. (XLSX 24 kb)
Additional file 7: Figure S3. Differential expression of merozoite
invasion-related genes among schizonts from different parasite cultures.
Distributions of read counts (normalised to library size) for eight genes,
for replicated laboratory-adapted and clinical isolate samples, showing
data from each replicate culture preparation of each strain. (PDF 324 kb)
Additional file 8: Figure S3. Gene expression levels for eight genes
newly detected as differentially expressed among clinical isolates (Table
1). Distributions of read counts (normalised to library size) for eight
genes, showing data from each replicate culture preparation of each
strain. (PDF 84 kb)
Additional file 9: Sequence annotation file
Pf3D7.May2015.NoSplice.LSHTM.gtf (see Additional file 1 for explanatory
details). (GTF 2322 kb)
Additional file 10: Sequence annotation file GTF_VarRifStev_filtered
out.gtf (see Additional file 1 for explanatory details). (GTF 2102 kb)
Additional file 11: RNA-seq comparison of gene expression in paired E64-
treated and untreated P. falciparum 3D7 schizont preparations. (PDF 365 kb)
Acknowledgements
We are grateful to malaria patients who contributed blood samples for
analysis of parasite transcription, and to colleagues who supported the
clinical sample collection and initial laboratory processing. We are also
grateful to Mandy Sanders for support in sequencing some of the samples,
and to Alistair Miles and Antoine Claessens for help towards identification of
genomic coordinates of highly polymorphic sequences within genes.
Funding
Funding for the study was granted by the European Research Council (AdG-2011-
294428, https://erc.europa.eu/) to DJC, the Leverhulme Trust-Royal Society
(AA110050, https://royalsociety.org/) to GAA and DJC, the Biotechnology and
Biological Sciences Research Council (BBSRC, London Interdisciplinary Doctoral
Programme https://bbsrc.ukri.org/) to LM, SEH and DJC, and the Wellcome Trust
(098051, https://wellcome.ac.uk) to JCR. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
The datasets supporting the conclusions of this article, including the
read count matrices, are available in the Gene Expression Omnibus
(https://www.ncbi.nlm.nih.gov/geo/), entry: GSE113718 for the P.
falciparum RNA-seq data from the laboratory-adapted and cultured
clinical isolates, and in the European Nucleotide Archive (https://www.e-
bi.ac.uk/ena), study: ERP103955 for the P. falciparum RNA-seq data from
the first cycle ex vivo isolates.
Authors’ contributions
SJT contributed to technical design, performed parasite culture, RNA-seq data
analysis and drafted the manuscript. OD-I contributed to technical design,
performed parasite culture and RNA-seq data generation. LBS contributed to
technical design, performed parasite culture and RNA-seq data generation. SEH,
LM, and CWD assisted with RNA-seq bioinformatics data analysis. TDO advised
and gave input on RNA-seq bioinformatics data analysis and interpretation. LC
performed RNA-seq data generation. JCR contributed to technical design, RNA-
seq data generation and manuscript revision. GAA contributed to technical
design, managed sample collection and contributed to manuscript revision.
DJC designed and supervised the study, contributed to technical design and
RNA-seq data analysis and interpretation, and managed manuscript drafting
and revision. All authors read and approved the final manuscript.
Ethics approval
This study of clinical parasite transcriptomes was approved by the Ethics
committees of the Ghana Health Service, the Noguchi Memorial Institute for
Medical Research, University of Ghana, the Kintampo Health Research Centre,
the Navrongo Health Research Centre and the London School of Hygiene
and Tropical Medicine. Written informed consent was obtained from parents
or legal guardians of participating children with malaria, and additional
assent was received from the children.
Consent for publication
All authors declare consent for publication.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Pathogen Molecular Biology Department, London School of Hygiene and
Tropical Medicine, London, UK. 2Institute of Infection, Immunity and
Inflammation, University of Glasgow, Scotland, UK. 3Wellcome Sanger
Institute, Hinxton, Cambridge, UK. 4West African Centre for Cell Biology of
Infectious Pathogens, Department of Biochemistry, Cell and Molecular
Biology, University of Ghana, Legon, Ghana.
Received: 21 August 2018 Accepted: 16 November 2018
References
1. Mata J, Wilbrey A, Bahler J. Transcriptional regulatory network for sexual
differentiation in fission yeast. Genome Biol. 2007;8:R217.
2. Cases I, de Lorenzo V, Ouzounis CA. Transcription regulation and
environmental adaptation in bacteria. Trends Microbiol. 2003;11:248–53.
3. Cestari I, Stuart K. Transcriptional regulation of telomeric expression sites
and antigenic variation in trypanosomes. Curr Genomics. 2018;19:119–32.
4. Bozdech Z, Llinás M, Pulliam BL, Wong ED, Zhu J, de Risi JL. The
transcriptome of the intraerythrocytic developmental cycle of P falciparum.
PLoS Biol. 2003;1:e5.
5. Mackinnon MJ, Li J, Mok S, Kortok MM, Marsh K, Preiser PR, Bozdech Z.
Comparative transcriptional and genomic analysis of Plasmodium falciparum
field isolates. PLoS Pathog. 2009;5:e1000644.
6. Rovira-Graells N, Gupta AP, Planet E, Crowley VM, Mok S, Ribas de Pouplana
L, Preiser PR, Bozdech Z, Cortes A. Transcriptional variation in the malaria
parasite Plasmodium falciparum. Genome Res. 2012;22:925–38.
7. Amambua-Ngwa A, Tetteh KK, Manske M, Gomez-Escobar N, Stewart LB,
Deerhake ME, Cheeseman IH, Newbold CI, Holder AA, Knuepfer E, et al.
Population genomic scan for candidate signatures of balancing
selection to guide antigen characterization in malaria parasites. PLoS
Genet. 2012;8:e1002992.
8. Ochola LI, Tetteh KK, Stewart LB, Riitho V, Marsh K, Conway DJ. Allele
frequency-based and polymorphism-versus-divergence indices of balancing
selection in a new filtered set of polymorphic genes in Plasmodium
falciparum. Molr Biol Evol. 2010;27:2344–51.
Tarr et al. BMC Genomics          (2018) 19:894 Page 11 of 13
9. Osier FH, Mackinnon MJ, Crosnier C, Fegan G, Kamuyu G, Wanaguru M, Ogada
E, McDade B, Rayner JC, Wright GJ, et al. New antigens for a multicomponent
blood-stage malaria vaccine. Sci Trans Med. 2014;6:247ra102.
10. Richards JS, Arumugam TU, Reiling L, Healer J, Hodder AN, Fowkes FJ, Cross
N, Langer C, Takeo S, Uboldi AD, et al. Identification and prioritization of
merozoite antigens as targets of protective human immunity to
Plasmodium falciparum malaria for vaccine and biomarker development. J
Immunol. 2013;191:795–809.
11. Tetteh KK, Osier FH, Salanti A, Kamuyu G, Drought L, Failly M, Martin C,
Marsh K, Conway DJ. Analysis of antibodies to newly described Plasmodium
falciparum merozoite antigens supports MSPDBL2 as a predicted target of
naturally acquired immunity. Infect Immun. 2013;81:3835–42.
12. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, Maier AG,
Winzeler EA, Cowman AF. Molecular mechanism for switching of P. falciparum
invasion pathways into human erythrocytes. Science. 2005;309:1384–7.
13. Gomez-Escobar N, Amambua-Ngwa A, Walther M, Okebe J, Ebonyi A, Conway
DJ. Erythrocyte invasion and merozoite ligand gene expression in severe and
mild Plasmodium falciparum malaria. J Infect Dis. 2010;201:444–52.
14. Bowyer PW, Stewart LB, Aspeling-Jones H, Mensah-Brown HE, Ahouidi AD,
Amambua-Ngwa A, Awandare GA, Conway DJ. Variation in Plasmodium
falciparum erythrocyte invasion phenotypes and merozoite ligand gene
expression across different populations in areas of malaria endemicity. Infect
Immun. 2015;83:2575–82.
15. Hansen KD, Wu Z, Irizarry RA, Leek JT. Sequencing technology does not
eliminate biological variability. Nat Biotechnol. 2011;29:572–3.
16. Elowitz MB, Levine AJ, Siggia ED, Swain PS. Stochastic gene expression in a
single cell. Science. 2002;297:1183–6.
17. Schurch NJ, Schofield P, Gierlinski M, Cole C, Sherstnev A, Singh V, Wrobel
N, Gharbi K, Simpson GG, Owen-Hughes T, et al. How many biological
replicates are needed in an RNA-seq experiment and which differential
expression tool should you use? RNA. 2016;22:839–51.
18. Seo J, Gordish-Dressman H, Hoffman EP. An interactive power analysis
tool for microarray hypothesis testing and generation. Bioinformatics.
2006;22:808–14.
19. Busby MA, Stewart C, Miller CA, Grzeda KR, Marth GT. Scotty: a web tool for
designing RNA-Seq experiments to measure differential gene expression.
Bioinformatics. 2013;29:656–7.
20. Llinas M, Bozdech Z, Wong ED, Adai AT, DeRisi JL. Comparative whole
genome transcriptome analysis of three Plasmodium falciparum strains.
Nucleic Acids Res. 2006;34:1166–73.
21. Claessens A, Affara M, Assefa SA, Kwiatkowski DP, Conway DJ. Culture
adaptation of malaria parasites selects for convergent loss-of-function
mutants. Sci Rep. 2017;7:41303.
22. Kafsack BF, Rovira-Graells N, Clark TG, Bancells C, Crowley VM, Campino SG,
Williams AE, Drought LG, Kwiatkowski DP, Baker DA, et al. A transcriptional
switch underlies commitment to sexual development in malaria parasites.
Nature. 2014;507:248–52.
23. Cheeseman IH, Gomez-Escobar N, Carret CK, Ivens A, Stewart LB, Tetteh KK,
Conway DJ. Gene copy number variation throughout the Plasmodium
falciparum genome. BMC Genomics. 2009;10:353.
24. Jeffares DC, Pain A, Berry A, Cox AV, Stalker J, Ingle CE, Thomas A, Quail MA,
Siebenthall K, Uhlemann AC, et al. Genome variation and evolution of the
malaria parasite Plasmodium falciparum. Nat Genet. 2007;39:120–5.
25. Nair S, Nkhoma S, Nosten F, Mayxay M, French N, Whitworth J, Anderson T.
Genetic changes during laboratory propagation: copy number at the
reticulocyte-binding protein 1 locus of Plasmodium falciparum. Mol
Biochem Parasitol. 2010;172:145–8.
26. Daily JP, Scanfeld D, Pochet N, Le Roch K, Plouffe D, Kamal M, Sarr O,
Mboup S, Ndir O, Wypij D, et al. Distinct physiological states of Plasmodium
falciparum in malaria-infected patients. Nature. 2007;450:1091–5.
27. Pelle KG, Oh K, Buchholz K, Narasimhan V, Joice R, Milner DA, Brancucci NM,
Ma S, Voss TS, Ketman K, et al. Transcriptional profiling defines dynamics of
parasite tissue sequestration during malaria infection. Genome Medicine.
2015;7:19.
28. Lemieux JE, Gomez-Escobar N, Feller A, Carret C, Amambua-Ngwa A,
Pinches R, Day F, Kyes SA, Conway DJ, Holmes CC, et al. Statistical
estimation of cell-cycle progression and lineage commitment in
Plasmodium falciparum reveals a homogeneous pattern of transcription in
ex vivo culture. Proc Natl Acad Sci U S A. 2009;106:7559–64.
29. Joice R, Narasimhan V, Montgomery J, Sidhu AB, Oh K, Meyer E, Pierre-Louis
W, Seydel K, Milner D, Williamson K, et al. Inferring developmental stage
composition from gene expression in human malaria. PLoS Comp Biol.
2013;9:e1003392.
30. Rono MK, Nyonda MA, Simam JJ, Ngoi JM, Mok S, Kortok MM, Abdullah AS,
Elfaki MM, Waitumbi JN, El-Hassan IM, et al. Adaptation of Plasmodium
falciparum to its transmission environment. Nature Ecol Evol. 2017;1.
31. Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, Chotivanich K, Imwong M,
Pukrittayakamee S, Dhorda M, et al. Drug resistance. Population
transcriptomics of human malaria parasites reveals the mechanism of
artemisinin resistance. Science. 2015;347:431–5.
32. Cheeseman IH, Miller B, Tan JC, Tan A, Nair S, Nkhoma SC, De Donato M,
Rodulfo H, Dondorp A, Branch OH, et al. Population structure shapes copy
number variation in malaria parasites. Mol Biol Evol. 2016;33:603–20.
33. Otto TD, Wilinski D, Assefa S, Keane TM, Sarry LR, Bohme U, Lemieux J,
Barrell B, Pain A, Berriman M, et al. New insights into the blood-stage
transcriptome of Plasmodium falciparum using RNA-Seq. Mol Microbiol.
2010;76:12–24.
34. Peterson DS, Wellems TE. EBL-1, a putative erythrocyte binding protein of
Plasmodium falciparum, maps within a favored linkage group in two
genetic crosses. Mol Biochem Parasitol. 2000;105:105–13.
35. Nacer A, Roux E, Pomel S, Scheidig-Benatar C, Sakamoto H, Lafont F, Scherf
A, Mattei D. Clag9 is not essential for PfEMP1 surface expression in non-
cytoadherent Plasmodium falciparum parasites with a chromosome 9
deletion. PLoS One. 2011;6:e29039.
36. Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, van
Schalkwyk DA, Sawa P, Omar SA, Clark TG, et al. Directional selection at the
pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in
Kenyan children treated with ACT. J Infect Dis. 2014;210:2001–8.
37. Filarsky M, Fraschka SA, Niederwieser I, Brancucci NMB, Carrington E, Carrio
E, Moes S, Jenoe P, Bartfai R, Voss TS. GDV1 induces sexual commitment of
malaria parasites by antagonizing HP1-dependent gene silencing. Science.
2018;359:1259–63.
38. Brancucci NMB, Bertschi NL, Zhu L, Niederwieser I, Chin WH, Wampfler R,
Freymond C, Rottmann M, Felger I, Bozdech Z, et al. Heterochromatin
protein 1 secures survival and transmission of malaria parasites. Cell Host
Microbe. 2014;16:165–76.
39. Carter R, Graves PM, Creasey A, Byrne K, Read D, Alano P, Fenton B.
Plasmodium falciparum: an abundant stage-specific protein expressed
during early gametocyte development. Exp Parasitol. 1989;69:140–9.
40. Lu XM, Batugedara G, Lee M, Prudhomme J, Bunnik EM, Le Roch KG.
Nascent RNA sequencing reveals mechanisms of gene regulation in the
human malaria parasite Plasmodium falciparum. Nucleic Acids Res. 2017;
45:7825–40.
41. Fraschka SA, Filarsky M, Hoo R, Niederwieser I, Yam XY, Brancucci NMB,
Mohring F, Mushunje AT, Huang X, Christensen PR, et al. Comparative
heterochromatin profiling reveals conserved and unique epigenome
signatures linked to adaptation and development of malaria parasites. Cell
Host Microbe. 2018;23:407–20.
42. Ntumngia FB, Bouyou-Akotet MK, Uhlemann AC, Mordmuller B, Kremsner PG,
Kun JF. Characterisation of a tryptophan-rich Plasmodium falciparum antigen
associated with merozoites. Mol Biochem Parasitol. 2004;137:349–53.
43. Morita M, Takashima E, Ito D, Miura K, Thongkukiatkul A, Diouf A, Fairhurst
RM, Diakite M, Long CA, Torii M, et al. Immunoscreening of Plasmodium
falciparum proteins expressed in a wheat germ cell-free system reveals a
novel malaria vaccine candidate. Sci Rep. 2017;7:46086.
44. Robinson MD, Smyth GK. Moderated statistical tests for assessing differences
in tag abundance. Bioinformatics. 2007;23:2881–7.
45. Balaji S, Babu MM, Iyer LM, Aravind L. Discovery of the principal specific
transcription factors of Apicomplexa and their implication for the evolution
of the AP2-integrase DNA binding domains. Nucleic Acids Res. 2005;33:
3994–4006.
46. Zhang M, Wang C, Otto TD, Oberstaller J, Liao X, Adapa SR, Udenze K,
Bronner IF, Casandra D, Mayho M, et al. Uncovering the essential genes of
the human malaria parasite Plasmodium falciparum by saturation
mutagenesis. Science. 2018;360.
47. Duffy S, Avery VM. Routine in vitro culture of Plasmodium falciparum:
experimental consequences? Trends Parasitol. 2018;34:564–75.
48. Kumar K, Srinivasan P, Nold MJ, Moch JK, Reiter K, Sturdevant D, Otto TD, Squires
RB, Herrera R, Nagarajan V, et al. Profiling invasive Plasmodium falciparum
merozoites using an integrated omics approach. Sci Rep. 2017;7:17146.
49. Doerig C, Rayner JC, Scherf A, Tobin AB. Post-translational protein
modifications in malaria parasites. Nat Rev Microbiol. 2015;13:160–72.
Tarr et al. BMC Genomics          (2018) 19:894 Page 12 of 13
50. Jones ML, Collins MO, Goulding D, Choudhary JS, Rayner JC. Analysis of
protein palmitoylation reveals a pervasive role in Plasmodium development
and pathogenesis. Cell Host Microbe. 2012;12:246–58.
51. Poran A, Notzel C, Aly O, Mencia-Trinchant N, Harris CT, Guzman ML,
Hassane DC, Elemento O, Kafsack BFC. Single-cell RNA sequencing reveals a
signature of sexual commitment in malaria parasites. Nature. 2017;551:95–9.
52. Reid AJ, Talman AM, Bennett HM, Gomes AR, Sanders MJ, Illingworth CJR,
Billker O, Berriman M, Lawniczak MK. Single-cell RNA-seq reveals hidden
transcriptional variation in malaria parasites. eLife. 2018;7:e33105.
53. Walzer KA, Kubicki DM, Tang X, Chi JT. Single-cell analysis reveals distinct
gene expression and heterogeneity in male and female Plasmodium
falciparum gametocytes. mSphere. 2018;3:e00130.
54. Lee HJ, Georgiadou A, Otto TD, Levin M, Coin LJ, Conway DJ, Cunnington AJ.
Transcriptomic studies of malaria: a paradigm for investigation of systemic
host-pathogen interactions. Microbiol Mol Biol Rev. 2018;82:e00071.
55. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, Turner DJ.
Amplification-free Illumina sequencing-library preparation facilitates
improved mapping and assembly of (G+C)-biased genomes. Nat Methods.
2009;6:291–5.
56. Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low
memory requirements. Nat Methods. 2015;12:357–60.
57. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis
G, Durbin R, Genome Project Data Processing S. The sequence alignment/
map format and SAMtools. Bioinformatics. 2009;25:2078–9.
58. Lawrence M, Huber W, Pages H, Aboyoun P, Carlson M, Gentleman R,
Morgan MT, Carey VJ. Software for computing and annotating genomic
ranges. PLoS Comp Biol. 2013;9:e1003118.
59. Love MI, Huber W, Anders S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
60. Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L,
Theander TG. Selective upregulation of a single distinctly structured var
gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in
pregnancy-associated malaria. Mol Microbiol. 2003;49:179–91.
Tarr et al. BMC Genomics          (2018) 19:894 Page 13 of 13
